219 related articles for article (PubMed ID: 28599664)
1. Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.
Pei N; Mao Y; Wan P; Chen X; Li A; Chen H; Li J; Wan R; Zhang Y; Du H; Chen B; Jiang G; Xia M; Sumners C; Hu G; Gu D; Li H
J Exp Clin Cancer Res; 2017 Jun; 36(1):77. PubMed ID: 28599664
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo.
Du H; Liang Z; Zhang Y; Jie F; Li J; Fei Y; Huang Z; Pei N; Wang S; Li A; Chen B; Zhang Y; Sumners C; Li M; Li H
PLoS One; 2013; 8(12):e83754. PubMed ID: 24391821
[TBL] [Abstract][Full Text] [Related]
3. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis.
Wang X; Lu J; Khaidakov M; Mitra S; Ding Z; Goyal T; Mehta JL
Apoptosis; 2012 Aug; 17(8):908-15. PubMed ID: 22527949
[TBL] [Abstract][Full Text] [Related]
5. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.
Liu Y; Li B; Wang X; Li G; Shang R; Yang J; Wang J; Zhang M; Chen Y; Zhang Y; Zhang C; Hao P
Mol Med; 2015 Jul; 21(1):626-36. PubMed ID: 26225830
[TBL] [Abstract][Full Text] [Related]
7. Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.
Carl-McGrath S; Ebert MP; Lendeckel U; Röcken C
Cancer Biol Ther; 2007 Aug; 6(8):1218-26. PubMed ID: 18059164
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.
Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C
Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275
[TBL] [Abstract][Full Text] [Related]
9. Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.
Tanaka N; Miyajima A; Kosaka T; Shirotake S; Hasegawa M; Kikuchi E; Oya M
Mol Cancer Ther; 2010 Nov; 9(11):2982-92. PubMed ID: 20978160
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
[TBL] [Abstract][Full Text] [Related]
11. Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.
Nguyen L; Ager EI; Neo J; Christophi C
J Gastroenterol Hepatol; 2016 Oct; 31(10):1773-1782. PubMed ID: 26849969
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.
Ma YP; Yang Y; Jiang SM; Liu L; Zhang Z; Wang YN; Zou GM; Li WG
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320919607. PubMed ID: 32370637
[TBL] [Abstract][Full Text] [Related]
13. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.
Mansoori A; Oryan S; Nematbakhsh M
J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor signaling and prostate tumor growth in mice.
Scott-Emuakpor J; Allot E; Johnson SA; Howard LE; Macias E; Freedland SJ; Gurley SB
J Exp Ther Oncol; 2017 Sep; 11(2):107-115. PubMed ID: 28976133
[TBL] [Abstract][Full Text] [Related]
15. A precision-guided MWNT mediated reawakening the sunk synergy in RAS for anti-angiogenesis lung cancer therapy.
Su Y; Hu Y; Wang Y; Xu X; Yuan Y; Li Y; Wang Z; Chen K; Zhang F; Ding X; Li M; Zhou J; Liu Y; Wang W
Biomaterials; 2017 Sep; 139():75-90. PubMed ID: 28595131
[TBL] [Abstract][Full Text] [Related]
16. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C.
Inuzuka T; Fujioka Y; Tsuda M; Fujioka M; Satoh AO; Horiuchi K; Nishide S; Nanbo A; Tanaka S; Ohba Y
Sci Rep; 2016 Feb; 6():21613. PubMed ID: 26857745
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells.
Liu M; Jing D; Wang Y; Liu Y; Yin S
Mol Cell Biochem; 2015 Feb; 400(1-2):233-44. PubMed ID: 25430897
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial angiotensin receptors and cardioprotective pathways.
Escobales N; Nuñez RE; Javadov S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1426-H1438. PubMed ID: 30978131
[TBL] [Abstract][Full Text] [Related]
20. The Network of Angiotensin Receptors in Breast Cancer.
Acconcia F
Cells; 2020 May; 9(6):. PubMed ID: 32471115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
